Results for News (Other Results)
Business and unions are often found at opposite ends of an issue. But Phil Knight's $500 million challenge to cure cancer appears to have united the old foes.
News | local | Sports | OPB News BlogSept. 29, 2014 8:21 p.m.
The University of Oregon Ducks will be looking pretty in pink in October to kick off Breast Cancer Awareness month.
News | local | OPB News BlogOct. 21, 2014 9:01 p.m.
Breast Cancer Awareness Month will wrap up in less than two weeks, but Washington state is bringing more attention to the disease that affects one in eight women in the U.S.
Oregon Health & Science University has reached its $500 million fundraising goal for the school's cancer research campaign.
local | Health | News | Vital SignsMarch 18, 2014 8:19 p.m.
State representative Vicki Berger says she expects to get the results of a study into the prevalence of the rare disease by the end of Tuesday, despite reports the state won't release them.
local | Health | News | Vital SignsOct. 22, 2013 9:52 p.m.
A Portland woman who says a drug from Novo Nordisk gave her breast cancer will get her day in court, after a ruling by the U.S. Supreme Court.
local | Health | Vital SignsSept. 20, 2013 8:23 p.m.
The American Cancer Society wants more Northwesterners to sign up for the latest phase of a sweeping study
local | Health | News | Vital SignsAug. 22, 2013 12:45 p.m.
One of the ways the federal government hopes to reform health care, is to get doctors to follow what are known as "best practices."
When photographer Jock Bradley’s sister died from ovarian cancer last year, his grief and experience dealing with her illness led to the birth of a new art project. Now a website and budding outreach organization, Portraits of Cancer documents the realities of life for people struggling with the disease.
The three-part PBS film "The Emperor of All Maladies" includes discussion of the cancer breakthrough drug Gleevec, developed by OHSU researcher, Brian Druker.
Randall Children's Hospital, in partnership with Pablove Shutterbug Photography, facilitated a grant from the Livestrong Foundation to allow children with cancer to learn fundamentals of photography.
Jenny Conlee, the accordionist, pianist and keyboard player for the Decemberists and Black Prairie, talks about her experience going through treatment and coming out the other side.
Andrea Leggitt's laser-cut designs draw on familiar memes like Grumpy Cat and cult favorites like Twin Peaks. She found an audience of "Internet nerds" during her battle with Hodgkin’s lymphoma.
An advisory panel to the National Cancer Institute has recommended changing the names of some precancerous tumors in an effort to lower overdiagnosis and overtreatment.
The idea is that the word cancer can cause such trauma and fear that it leads to rash and unnecessary procedures. An example of a cancer the panel recommends downgrading is ductal carcinoma in situ (DCIS), what is sometimes called stage 0 breast cancer. Some women undergo mastectomies and chemotherapy to destroy tumors that likely would have never left the milk duct.
This sort of pulling back from cancer detection and treatment has been a hard sell for doctors, thanks in large part to their successes educating the public about cancer. For decades, the most persistent mantra about cancer was early detection. If cancers could be found at nascent stages, the reasoning went, more people could be saved. More and better screenings ensued. Until a few years ago, this was considered great news. Now, though, there's a growing belief among doctors and researchers that more detection hasn't led to greater survival rates and it may even cause more harm than good with some cancers. The most famous example of this change in thinking came in 2009 when the guidelines for mammograms were changed, having women start screening later and less frequently.
Last Friday, the Health Evidence Review Commission approved Guideline 12, a measure they say will open up care for more cancer patients under the Oregon Health Plan. The new guidelines did away with a stipulation that restricted treatment for patients with less than two years to live. Still, there are those who oppose the measure, arguing that legislating cancer treatment based on things like age and life expectancy is illegal under the Affordable Care Act.